Organic Acids Test (OAT) Interpretation Guide

The complete reference for FM practitioners — from mitochondrial markers and gut bacteria to oxalates, detoxification pathways, and neurotransmitter metabolites. Everything you need to go from raw OAT results to a clinical action plan.

Bookmark this. If you're ordering OATs in your practice, you'll come back here.

I order an OAT on almost every new functional medicine patient. One first-morning urine specimen — and you get a functional map of mitochondrial energy production, gut microbial metabolite activity, oxalate accumulation, hepatic detoxification status, and systemic neurotransmitter turnover. The density of actionable clinical data per dollar is unmatched in our toolkit.

The challenge isn't finding the information. The OAT gives you more than most practitioners know what to do with. The challenge is knowing which markers to prioritize, what patterns mean taken together, and how to build a treatment protocol that doesn't overwhelm your patient or you. That's what this guide is for.

This is organic acids test interpretation for functional medicine practitioners — the full picture, from marker categories through pattern recognition to clinical action.

---

Table of Contents

1. What the OAT Measures — and Why It's Unique
2. OAT vs. Other Functional Labs: When to Order It
3. Mitochondrial Markers: Reading the Energy Production Picture
4. Gut Bacteria Markers: Yeast, Clostridia, and Dysbiosis
5. Oxalate Markers: Dietary, Metabolic, and Fungal Sources
6. Detoxification Markers: Phase I, Phase II, and the Glutathione System
7. Neurotransmitter Metabolites: Dopamine, Serotonin, and Norepinephrine
8. Nutritional Markers: Functional B-Vitamin and Antioxidant Status
9. How to Read an OAT: Pattern Recognition Framework
10. OAT Interpretation: A Clinical Decision Framework
11. Great Plains vs. MosaicDX: Which OAT Panel to Order
12. How to Explain OAT Results to Patients
13. Case Studies
14. FAQ

---

1. What the OAT Measures — and Why It's Unique

The Organic Acids Test measures small molecules in urine — organic acids — that are metabolic byproducts of cellular processes: energy metabolism, neurotransmitter synthesis and breakdown, detoxification reactions, and microbial fermentation in the gut. Most are intermediaries or end-products of specific biochemical pathways. When a pathway is stressed, impaired, or overloaded, the corresponding organic acid accumulates in urine and gets flagged on the report.

This is what separates the OAT from serum labs. You're not capturing a hormone level or a nutrient snapshot at a point in time. You're measuring whether the biochemical pathways are actually working — functional output, not circulating levels. A patient can have a serum B12 of 400 pg/mL and still show elevated methylmalonic acid on OAT, which tells you cellular B12 utilization is impaired. The serum result would have sent you home. The OAT catches it.

Marker Categories at a Glance

Category	What It Measures	Clinical Insight
Mitochondrial / Energy	Krebs cycle intermediates, glycolysis, fatty acid oxidation	Whether cells are producing energy efficiently
Gut Microbial	Yeast fermentation products, Clostridia metabolites, general dysbiosis markers	What gut microbes are doing metabolically
Oxalates	Oxalic acid, glyceric acid, glycolic acid	Sources and magnitude of oxalate load
Detoxification	Glucaric acid, pyroglutamic acid, orotic acid, alpha-hydroxybutyrate	Phase I/II hepatic load, glutathione system status
Neurotransmitters	HVA (dopamine), VMA (norepinephrine/epinephrine), 5-HIAA (serotonin)	Systemic neurotransmitter turnover
Nutritional	B-vitamin functional markers, CoQ10, carnitine	Functional cofactor status independent of serum levels
Oxidative Stress	8-OHdG, isoprostanes	DNA oxidative damage load

What the OAT Does NOT Measure

The OAT doesn't give you everything. It doesn't measure active serum hormone levels, identify gut organisms directly (it captures their metabolites — not the organisms themselves), reveal genetic variants like MTHFR or COMT, or quantify heavy metals. For organism-level gut identification, you need a stool panel like GI-MAP. For metals, a urine toxic metals panel. For SNPs, genetic testing.

Think of the OAT as a functional layer — a window into what your patient's biochemistry is actually doing. It generates hypotheses. Other tests confirm them.

---

2. OAT vs. Other Functional Labs: When to Order It

Working through a complex lab panel? See the full Lab Interpretation Hub — comparison library covering GI-MAP, DUTCH, NutrEval, and more.

Order the OAT When

In practice, the OAT earns its keep in the following clinical situations:

• Patient presents with chronic fatigue, brain fog, mood dysregulation, or unexplained neurological symptoms
• You suspect gut dysbiosis but want functional metabolite data, not just organism counts
• Mitochondrial dysfunction is in your differential
• Patient has a history of recurrent yeast infections, heavy antibiotic use, or known mold exposure
• Serum labs are unremarkable but the patient clearly isn't well
• You want biochemical confirmation of treatment response to antifungal, antimicrobial, or mitochondrial support protocols
• Oxalate-related symptoms: kidney stones, joint pain, fibromyalgia, vulvodynia, or interstitial cystitis
• Toxin or detox burden is suspected — solvent exposure, mycotoxin history, heavy medication load

OAT vs. GI-MAP

The question I get most often from practitioners new to OAT ordering: "Do I need both OAT and GI-MAP, or will one cover it?" Both — in complex cases. They're complementary, not redundant.

Dimension	OAT	GI-MAP
What it detects	Microbial metabolites in urine (functional)	Direct organism identification in stool
Yeast	Arabinose, tartaric acid (metabolites)	Candida species (organism counts)
Bacteria	Clostridia metabolites, dysbiosis markers	Specific bacterial pathogens, H. pylori
Systemic reach	Systemic — reflects what microbes are doing throughout the body	Local — gut environment only
Mitochondrial data	Yes — extensive	No
Detox markers	Yes	No
Best use	Functional metabolic picture; neurological/systemic dysbiosis effects	Pathogen identification; specific treatment targeting

Rule of thumb: OAT tells you what's happening systemically; GI-MAP tells you who's in the gut. The OAT shows you that Candida is active and producing metabolites affecting your patient's cognition — the GI-MAP confirms which species and provides organism counts for treatment targeting. In complex cases, run both.

---

3. Mitochondrial Markers: Reading the Energy Production Picture

The mitochondrial section of the OAT is the most mechanistically direct. It maps the major energy production pathways — glycolysis, the citric acid (Krebs) cycle, and fatty acid beta-oxidation — and tells you exactly where the dysfunction is. When I see a patient with profound fatigue and exercise intolerance and their basic metabolic panel looks fine, this is where I go first.

### Glycolytic Markers: Pyruvate and Lactate

| Marker | Elevated Interpretation | Key Associations |
|--------|------------------------|-----------------|
| **Pyruvic acid** | Glycolysis → Krebs cycle entry is blocked | Thiamine (B1) deficiency; pyruvate dehydrogenase dysfunction |
| **Lactic acid** | Anaerobic metabolism predominance | B1 deficiency; mitochondrial membrane damage; tissue hypoxia; magnesium deficiency |

Elevated pyruvate alongside elevated lactate is a specific signal: pyruvate cannot enter the Krebs cycle efficiently. The cell defaults to anaerobic fermentation, lactate accumulates, and the patient has fatigue, exercise intolerance, and post-exertional malaise that mirrors long COVID or CFS/ME presentations. Thiamine (B1) is the cofactor for pyruvate dehydrogenase, and functional B1 deficiency is more common than most practitioners recognize — particularly in patients eating high-carbohydrate diets or recovering from significant illness.

### Krebs Cycle Intermediates

| Marker | Elevated Interpretation | Cofactor Implicated |
|--------|------------------------|-------------------|
| **Citric acid** | Candida/yeast produce citrate; low suggests poor Krebs entry | — |
| **Succinic acid** | Complex II dysfunction; succinate dehydrogenase impairment | Riboflavin (B2), CoQ10 |
| **Fumaric acid** | Fumarase impairment; associated with mycotoxin exposure | — |
| **Malic acid** | Malate dehydrogenase impairment | NAD+ (niacin, B3) |
| **2-Oxoglutaric acid (alpha-ketoglutarate)** | Elevated = Krebs cycle block; low = insufficient substrate | B3, B5, CoQ10 |

When multiple Krebs cycle intermediates are elevated simultaneously, the pattern points to a systemic upstream bottleneck — typically CoQ10 deficiency, statin-induced mitochondrial suppression, or concurrent B-vitamin cofactor deficiencies. I see this pattern regularly in patients who have been on statins for more than a year and who present with fatigue that gets attributed to aging or deconditioning.

### Fatty Acid Oxidation Markers

| Marker | Elevated Interpretation | Key Associations |
|--------|------------------------|-----------------|
| **Suberic acid** | Impaired beta-oxidation of medium-chain fatty acids | Carnitine deficiency; riboflavin deficiency |
| **Adipic acid** | Adipate accumulation from fatty acid oxidation block | Carnitine deficiency, B2 deficiency |
| **Ethylmalonic acid** | Short-chain beta-oxidation impairment | Riboflavin (B2) deficiency; possibly genetic |
| **Methylsuccinic acid** | Odd-chain fatty acid oxidation impairment | B12 (methylcobalamin), B5 |

When fatty acid markers are elevated, the cell cannot efficiently burn fat for energy. This is clinically relevant for patients who exercise without seeing metabolic results, have profound morning fatigue when fat-burning should be peaking, or carry a metabolic syndrome diagnosis without a satisfying mechanistic explanation.

> **Deep dive:** [OAT Mitochondrial Function Markers Explained](/support/oat/oat-mitochondrial) — complete marker-by-marker reference with B-vitamin cofactor map and treatment protocols.

---

## 4. Gut Bacteria Markers: Yeast, Clostridia, and Dysbiosis

This is where the OAT frequently surprises even experienced practitioners. The gut microbial markers detect active Candida and Clostridia overgrowth through urinary metabolites, offering a systemic functional picture that stool testing alone misses. A patient with significant Clostridia overgrowth affecting neurotransmitter balance can have a normal-looking stool panel. The OAT catches it.

### Yeast Markers: Arabinose and Tartaric Acid

| Marker | Source | Clinical Significance |
|--------|--------|-----------------------|
| **Arabinose** | *Candida* fermentation; Candida converts glucose to arabinitol, which converts to arabinose | Most reliable single yeast marker; elevated in active Candida overgrowth |
| **Tartaric acid** | Yeast fermentation; also inhibits Krebs cycle enzymes (malic dehydrogenase) | Co-elevation with arabinose = Candida strongly implicated; explains secondary energy impairment |
| **Citric acid** (microbial context) | Yeast produce citric acid as a fermentation byproduct | Can elevate secondary to yeast burden; interpret alongside arabinose |
| **5-Hydroxymethyl-2-furoic acid** | Fungal metabolite | Tracks with yeast burden; useful confirmatory marker |

In practice: elevated arabinose plus tartaric acid equals Candida overgrowth until proven otherwise. The symptom complex that maps to this pattern is recognizable once you've seen it a few times — sugar cravings, post-meal bloating, diffuse brain fog worse in the afternoon, fatigue that doesn't respond to sleep, and often a history of recurrent vaginal yeast infections or oral thrush.

One important caveat: dietary arabinose exists in fruits and vegetables. High arabinose without other yeast markers warrants a dietary review before launching into antifungal treatment.

### Clostridia Markers: The Neurotransmitter Connection

The Clostridia-neurotransmitter link is clinically underappreciated and mechanistically important. Clostridia species in the gut produce phenolic metabolites that directly inhibit dopamine-beta-hydroxylase (DBH) — the enzyme that converts dopamine to norepinephrine. The neurochemical consequence is significant and frequently misread as a primary psychiatric presentation.

| Marker | Producing Organism | Mechanism | Clinical Effect |
|--------|------------------|-----------|-----------------|
| **HPHPA** | *C. sporogenes*, *C. botulinum*, *C. caloritolerans* | DBH inhibitor; blocks dopamine-to-norepinephrine conversion | Elevated dopamine, depleted norepinephrine — anxiety, OCD-like symptoms, behavioral dysregulation |
| **4-Cresol** | Same Clostridia species | Inhibits DBH and tyrosine hydroxylase | Mood dysregulation; elevated in autism spectrum research |
| **3-Indoleacetic acid** | Clostridia tryptophan metabolism | Signals deeper Clostridia activity | Broader dysbiosis indicator |

**The HVA:VMA ratio as confirmation:** When HPHPA is elevated, cross-reference the neurotransmitter section. A high HVA:VMA ratio — dopamine metabolite elevated relative to norepinephrine metabolite — confirms downstream DBH inhibition. This is the biochemical fingerprint of active Clostridia overgrowth disrupting neurotransmitter balance.

In practice, I have seen patients referred from psychiatry for anxiety and OCD-like symptoms who had dramatically elevated HPHPA with corresponding HVA:VMA abnormalities. Treating the Clostridia overgrowth — antimicrobial herbs or oral vancomycin in severe cases — produced mood improvement that SSRIs had not touched. The gut was the primary driver. The OAT found it.

[DIAGRAM: Clostridia HPHPA to DBH Inhibition to Neurotransmitter Imbalance] Suggestion: Simple linear pathway diagram. Tyrosine → Dopamine → [DBH blocked by HPHPA/4-Cresol from Clostridia] → Norepinephrine (reduced) Show: elevated HVA (dopamine metabolite builds up), reduced VMA (norepinephrine metabolite drops) AI prompt: "Simple medical pathway diagram. Arrows left to right: Tyrosine → Dopamine → [BLOCKED: DBH inhibited by HPHPA from Clostridia bacteria] → Norepinephrine (reduced). Below the block: elevated HVA (dopamine metabolite). Clinical infographic style, muted blue-gray tones. Clostridia labeled in red callout. Clean minimal design, white background."

### General Dysbiosis Markers: Phenolic Compounds

| Marker | What It Reflects | Pattern Interpretation |
|--------|-----------------|----------------------|
| **Benzoate / Hippurate** | Bacterial fermentation of aromatic amino acids; hippurate reflects glycine conjugation capacity | Elevated = bacterial overgrowth plus conjugation load |
| **Phenylpropionate / Phenylacetate** | Phenylalanine/tyrosine bacterial fermentation | Elevated = dysbiosis, SIBO pattern |
| **Indican** | Tryptophan bacterial fermentation | Elevated = SIBO or general dysbiosis |
| **D-lactate** | Produced by Lactobacillus/Bifidobacterium overgrowth | Can indicate D-lactic acidosis in severe SIBO |

No single dysbiosis marker is diagnostic on its own. Multiple elevated phenolic compounds together — even when each is borderline individually — signal broad bacterial dysbiosis. Learn to read the pattern, not the individual marker in isolation.

> **Deep dive:** [Gut Bacteria Markers on the Organic Acids Test](/support/oat/oat-gut-bacteria) — complete yeast, Clostridia, and dysbiosis marker reference with treatment framework, HPHPA mechanism diagram, and clinical case study.

---

## 5. Oxalate Markers: Dietary, Metabolic, and Fungal Sources

High oxalates is a finding many practitioners see on OAT reports without a clear treatment framework. The key clinical insight: **the source of the oxalate determines the treatment**. There are three distinct origins, and conflating them leads to protocols that partially work at best.

The Three OAT Oxalate Markers

Marker	What It Measures
Oxalic acid	Total oxalate load; primary marker
Glyceric acid	Endogenous glyoxylate pathway activity
Glycolic acid	Glyoxylate pathway; also reflects vitamin C to oxalate conversion

The Three Sources of Elevated Oxalates

Source 1 — Dietary Hyperoxaluria

The usual suspects: spinach, almonds, beets, chocolate, sweet potatoes, rhubarb, peanuts. If oxalic acid is elevated and arabinose and tartaric acid are normal, this is where I start — dietary review before any supplement protocol.

Source 2 — Endogenous Metabolic Production

The glyoxylate pathway converts glycolate and glyoxylate to oxalate. The enzyme that clears glyoxylate — alanine-glyoxylate aminotransferase (AGT) — requires vitamin B6 (pyridoxal-5-phosphate) as its cofactor. B6 deficiency means glyoxylate accumulates and converts to oxalate. This pathway also explains how megadose vitamin C supplementation can drive oxalate elevation (vitamin C → dehydroascorbate → glyoxylate → oxalate). Elevated glycolic acid alongside oxalic acid, without yeast markers, points to this endogenous route.

Source 3 — Candida/Fungal Production

Candida produces oxalic acid directly as a metabolic byproduct. When oxalic acid is elevated alongside arabinose and tartaric acid, Candida is almost certainly the driver. This triple pattern — oxalic acid plus arabinose plus tartaric acid — is the classic fungal-driven oxalate signature. In this case, modifying diet first is a partial approach. The yeast has to go.

Downstream Effects of High Oxalates

High systemic oxalate is not just a kidney stone risk. Oxalate directly inhibits ATP synthesis, which explains why high-oxalate patients so often have concurrent mitochondrial markers elevated on OAT. Oxalate also binds calcium and magnesium in tissues — depleting available mineral pools — and deposits as calcium oxalate crystals in kidneys, joints, blood vessels, and soft tissue. The fibromyalgia-like pain pattern in some patients reflects crystal deposition, not a primary pain syndrome. Oxalate also destroys Oxalobacter formigenes — the gut bacterium that degrades dietary oxalate before systemic absorption — creating a self-reinforcing cycle.

Treatment Framework

Layer	Intervention
Reduce load	Low-oxalate diet; treat Candida if arabinose and tartaric acid are elevated
Block absorption	Calcium citrate 500mg with meals (binds oxalate in gut lumen before absorption)
Support metabolism	P-5-P (B6) 50-100mg/day (AGT cofactor); magnesium citrate (anti-crystallization)
Restore gut degraders	Lactobacillus acidophilus, L. gasseri (shown to degrade oxalate); adequate hydration
Monitor	Retest OAT at 12 weeks; counsel patient on oxalate-dumping symptoms (temporary worsening during treatment)

Deep dive: Oxalates and Detoxification on OAT — full oxalate source differentiation, detox marker interpretation, treatment protocols, and clinical case study.

---

6. Detoxification Markers: Phase I, Phase II, and the Glutathione System

The detox section of the OAT is routinely underread. Most practitioners spend time in the gut and mitochondrial sections and move on — missing a hepatic detoxification picture that often explains symptoms the other sections don't account for. These markers can reveal active toxin exposure, glutathione depletion, and urea cycle stress that collectively explain chemical sensitivity, medication intolerance, and persistent fatigue when everything else looks workable.

Key Detox Markers Reference Table

Marker	What It Reflects	Elevated Means	Action
Glucaric acid	Phase I hepatic CYP450 induction	High toxin, drug, or xenobiotic load on liver	Identify and reduce source; support Phase I with B vitamins
2-Methylhippuric acid	Xylene/solvent exposure	Recent or ongoing VOC exposure (paints, solvents, fuels)	Environmental exposure history; Phase II support
Orotic acid	Ammonia/urea cycle stress	Excess ammonia from dysbiosis, arginine deficiency, or liver stress	Treat dysbiosis; arginine/citrulline supplementation
Alpha-hydroxybutyric acid	Glutathione synthesis demand	Body upregulating glutathione — early detox strain signal	NAC, glycine, alpha-lipoic acid
Pyroglutamic acid	Gamma-glutamyl cycle impairment	Glutathione recycling blocked — glycine deficiency or oxidative depletion	Liposomal or IV glutathione; NAC; glycine supplementation
Sulfate	Total glutathione reserve proxy	Low sulfate = system-wide glutathione depletion	Address root cause; direct glutathione repletion

Reading the Detox Pattern

Elevated glucaric acid only: Phase I overload; the body is processing a high toxin or drug load but Phase II is still compensating. Priority: identify and reduce the source before it overwhelms downstream pathways.

Elevated alpha-hydroxybutyric acid: Early warning signal. The body is demanding more glutathione than it is producing. Intervene here — NAC and alpha-lipoic acid work well at this stage, before depletion is established.

Elevated pyroglutamic acid plus low sulfate: The glutathione recycling system has broken down. This is the depleted state. Precursors alone will not keep up — direct replenishment is required. Liposomal or IV glutathione is appropriate here.

Elevated glucaric acid plus elevated pyroglutamic acid together: The full picture — high toxin exposure and an overwhelmed detox system. Address both simultaneously. Removing the source without supporting glutathione repletion leaves the patient stuck. Supporting glutathione without removing the source is a losing battle.

Elevated orotic acid with dysbiosis markers: Ammonia-producing bacteria are stressing the urea cycle. Treat the dysbiosis first; orotic acid frequently normalizes without additional intervention.

The Candida-Oxalate-Detox Triad

These sections frequently co-elevate for a common underlying reason: Candida overgrowth simultaneously produces oxalic acid and tartaric acid (which inhibits the Krebs cycle), depleting cellular energy and consuming glutathione reserves in the process. When oxalate and detox sections are both abnormal, Candida-driven metabolic toxicity is often the unifying explanation. The antifungal protocol comes first, before glutathione loading becomes the focus.

Full detox marker framework: Oxalates and Detoxification on OAT — phase-by-phase breakdown with treatment sequencing and clinical case study.

---

7. Neurotransmitter Metabolites: Dopamine, Serotonin, and Norepinephrine

The neurotransmitter metabolite section is one of the most clinically actionable parts of the OAT — and the most frequently misinterpreted. These are urinary metabolites of neurotransmitter breakdown, not neurotransmitters themselves. They reflect systemic neurotransmitter turnover. That is a real limitation worth acknowledging, but the directional clinical signal is meaningful when interpreted in context.

The Key Neurotransmitter Markers

Marker	Reflects	Elevated	Low
HVA (homovanillic acid)	Dopamine turnover	Dopamine excess or catecholamine stress	Dopamine depletion — fatigue, low motivation, anhedonia
VMA (vanillylmandelic acid)	Epinephrine and norepinephrine turnover	Catecholamine excess, chronic sympathetic activation	Epinephrine/norepinephrine depletion
5-HIAA (5-hydroxyindoleacetic acid)	Serotonin turnover	High serotonin activity; can also reflect oxidative stress	Serotonin depletion — depression, mood instability, sleep disruption
Kynurenic acid / Xanthurenic acid	B6 functional status and kynurenine pathway activity	Functional B6 deficiency; tryptophan shunted from serotonin synthesis	—

The HVA:VMA Ratio — The Clostridia Link

As covered in Section 4, this ratio has a specific application beyond general neurotransmitter assessment. When HPHPA is elevated, the HVA:VMA ratio rises because DBH inhibition causes dopamine metabolites to accumulate relative to norepinephrine metabolites. Elevated HVA:VMA in the context of elevated HPHPA is not a primary neurotransmitter disorder. It is a gut bacteria problem generating a secondary neurotransmitter imbalance. These patients do not need an SSRI or stimulant adjustment — they need the Clostridia addressed. The distinction matters enormously in clinical practice.

Clinical Pattern Interpretation

High VMA plus low HVA: Catecholamine excess with dopamine depletion — the pattern of chronic high-stress, adrenal overactivation, and eventual motivational collapse. Supports catecholamine precursor loading with L-tyrosine alongside cortisol normalization protocols.

Low 5-HIAA plus low HVA: Both serotonin and dopamine pathways are depleted. Consider tryptophan or 5-HTP alongside L-tyrosine — but before layering precursors, rule out functional B6 deficiency. Elevated xanthurenic acid is a common root cause that depletes both pathways simultaneously, and P-5-P supplementation alone often normalizes both markers.

Elevated kynurenic acid plus xanthurenic acid: Functional B6 deficiency is shunting tryptophan down the kynurenine pathway and away from serotonin synthesis. P-5-P (50-100mg/day) typically resolves this pattern within weeks and improves mood without additional precursors.

---

## 8. Nutritional Markers: Functional B-Vitamin and Antioxidant Status

One underappreciated application of OAT interpretation is functional nutritional assessment. Serum B-vitamin levels may fall within range while functional deficiency is active downstream. The OAT captures the metabolic consequence of inadequate cofactor availability — which is what actually matters clinically. A patient can have a serum B12 of 400 pg/mL — technically within range — with elevated methylmalonic acid on OAT, indicating functional B12 deficiency at the cellular level. OAT catches it. Serum misses it.

### Key Nutritional Markers

| Marker | Nutrient Indicated | Elevated Means |
|--------|------------------|---------------|
| **Glutaric acid** | Riboflavin (B2) functional status | B2 deficiency or riboflavin-dependent enzyme impairment |
| **Methylmalonic acid (MMA)** | B12 (methylcobalamin) functional status | Functional B12 deficiency even when serum B12 is within range |
| **Xanthurenic acid / Kynurenic acid** | B6 (pyridoxal-5-phosphate) | Functional B6 deficiency; tryptophan shunting |
| **3-Hydroxyisovaleric acid** | Biotin functional status | Biotin deficiency |
| **Beta-OH-beta-methylglutaric acid** | HMG-CoA reductase activity; CoQ10 indicator | CoQ10 deficiency; commonly associated with statin use |
| **Pantothenic acid markers** | B5 (pantothenate) | B5 deficiency affecting CoA-dependent reactions |

The functional versus serum gap is clinically significant. If a patient presents with fatigue and you check serum B12 and it comes back at 400 pg/mL, conventional medicine stops there. But if MMA is elevated on OAT, the cells are not getting enough B12 to complete methylcobalamin-dependent reactions — regardless of what the serum level says. OAT-guided B12 repletion in these patients (sublingual or injectable methylcobalamin) often produces meaningful clinical improvement that serum-guided management missed.

### Oxidative Stress: 8-OHdG

8-hydroxy-2'-deoxyguanosine (8-OHdG) measures oxidative DNA damage — a direct indicator of systemic oxidative stress load.

**Elevated 8-OHdG is associated with:**
- Mitochondrial dysfunction generating reactive oxygen species
- Environmental toxin or mycotoxin exposure
- Chronic inflammation
- Metabolic syndrome and insulin resistance

**Protocol response:** Liposomal or IV glutathione (500mg/day), NAC (600mg BID), CoQ10 ubiquinol (200-400mg/day), ribose, alpha-lipoic acid. Address the driving mechanism — mitochondrial dysfunction, toxin exposure, or inflammation — not just the oxidative stress marker downstream.

---

## 9. How to Read an OAT: Pattern Recognition Framework

Experienced OAT interpreters do not read markers in isolation. The clinical value of organic acids test interpretation comes from pattern recognition — which sections are abnormal together, and what unifying mechanism explains them. A single elevated marker is a footnote. Three related markers elevated across two sections is a clinical story.

[INFOGRAPHIC: The Six OAT Clinical Patterns] Suggestion: Six-panel grid infographic. Each panel: Pattern name, key elevated markers, 1-sentence clinical picture, 1 first intervention. Panels: 1) Mitochondrial Energy Crisis, 2) Candida Overgrowth, 3) Clostridia + Neurotransmitter Disruption, 4) Oxalate + Detox Burden, 5) Detox Overload, 6) Mixed Dysbiosis AI prompt: "Six-panel medical infographic grid. Muted clinical colors, clean sans-serif."

### The Six Common OAT Patterns

**Pattern 1 — Mitochondrial Energy Crisis**
- Elevated: Lactic acid, pyruvic acid, multiple Krebs cycle intermediates, fatty acid oxidation markers
- Nutritional: Low CoQ10 indicator, functional B2 and B3 deficiency
- Clinical picture: Profound fatigue, exercise intolerance, post-exertional malaise
- Root cause: B-vitamin cofactor depletion, statin exposure, mold/mycotoxin, mitochondrial membrane damage
- First step: Rule out statin use; assess B-vitamin cofactors; CoQ10 loading trial

**Pattern 2 — Candida Overgrowth**
- Elevated: Arabinose, tartaric acid, oxalic acid (the fungal triple pattern)
- May also elevate: Citric acid, 5-hydroxymethyl-2-furoic acid
- Mitochondrial impact: Tartaric acid inhibits malate dehydrogenase → secondary mitochondrial markers may also elevate
- Clinical picture: Sugar cravings, bloating, brain fog, fatigue, recurrent yeast infections
- First step: Antifungal protocol (low-sugar diet, herbal antifungals, *S. boulardii*); address oxalate load concurrently

**Pattern 3 — Clostridia Overgrowth plus Neurotransmitter Disruption**
- Elevated: HPHPA, 4-cresol, elevated HVA:VMA ratio
- May also elevate: General dysbiosis markers (phenylpropionate, hippurate)
- Clinical picture: Anxiety, behavioral dysregulation, OCD-like symptoms, mood instability
- Root cause: Clostridia overgrowing post-antibiotic; dysbiosis creating permissive conditions
- First step: Antimicrobial protocol (herbs or oral vancomycin in severe cases); recolonization with *S. boulardii*

**Pattern 4 — Oxalate plus Detox Burden (Candida-Driven)**
- Elevated: Oxalic acid, arabinose/tartaric acid, glucaric acid, alpha-hydroxybutyric acid
- Clinical picture: Joint pain, fibromyalgia, recurrent kidney stones, chronic fatigue, pelvic pain
- Root cause: Candida driving oxalate production while depleting glutathione reserves
- First step: Treat Candida → low-oxalate diet → calcium citrate with meals → glutathione support

**Pattern 5 — Detox Overload (Environmental Toxin or Medication Load)**
- Elevated: Glucaric acid (often markedly), 2-methylhippuric acid, possibly pyroglutamic acid
- Clinical picture: Chemical sensitivities, inability to tolerate supplements, fatigue
- Root cause: High xenobiotic or mycotoxin load overwhelming Phase I; Phase II falling behind
- First step: Detailed environmental exposure history; reduce sources; NAC plus glutathione support

**Pattern 6 — Mixed Dysbiosis plus Nutritional Depletion**
- Elevated: Multiple dysbiosis markers (indican, phenylpropionate, hippurate) plus nutritional markers (glutaric acid, methylmalonic acid, xanthurenic acid)
- Clinical picture: Fatigue, mood symptoms, GI dysfunction, and brain fog — the everything-is-wrong presentation
- Root cause: Chronic dysbiosis depleting B-vitamins and impairing functional pathways systemically
- First step: 5R gut repair protocol; targeted B-vitamin repletion based on which functional markers are elevated

---

## 10. OAT Interpretation: A Clinical Decision Framework

Use this step-by-step framework to move from raw OAT results to a clinical action plan.

### Step 1: Scan for Urgency Flags

Before detailed analysis, identify any immediately actionable findings:
- Markedly elevated lactic acid (rule out serious metabolic condition or mitochondrial disease before proceeding)
- Elevated 2-methylhippuric acid (xylene exposure — get an environmental history immediately)
- Very high orotic acid in a pediatric patient (consider genetic urea cycle disorder)

### Step 2: Identify the Dominant Section

Which section has the most abnormal markers?
- Mitochondrial section dominant → energy production protocol is the priority
- Gut microbial section dominant → antimicrobial or antifungal protocol first
- Oxalate plus detox sections dominant → identify source (dietary, endogenous, or fungal)
- Neurotransmitter section dominant → check HPHPA and 4-cresol first (Clostridia link); assess B6 status via xanthurenic acid

### Step 3: Look for Connecting Patterns

Markers in different sections often share a root cause:
- Arabinose + tartaric acid + oxalic acid = Candida (connects gut and oxalate sections)
- HPHPA + elevated HVA:VMA = Clostridia disrupting dopamine (connects gut and neurotransmitter sections)
- Glucaric acid + pyroglutamic acid + elevated 8-OHdG = toxin overload depleting glutathione (connects detox and oxidative stress sections)
- Multiple Krebs intermediates + glutaric acid + CoQ10 marker = B-vitamin plus CoQ10 deficiency (connects mitochondrial and nutritional sections)

### Step 4: Build the Root Cause Narrative

Synthesize findings into a clinical interpretation the patient can act on:

> *"This patient has active Candida overgrowth — arabinose is 3x the upper limit of normal, tartaric acid is elevated — driving secondary oxalate accumulation (oxalic acid elevated) and Krebs cycle impairment via tartaric acid's inhibition of malate dehydrogenase. Concurrent glucaric acid elevation suggests the liver is working hard to process fungal metabolites. Alpha-hydroxybutyrate elevation signals early glutathione depletion. The treatment priority is antifungal first — the oxalate and detox markers will improve downstream as the fungal load drops."*

### Step 5: Prioritize Interventions

Address in sequence. Avoid giving the patient a 12-supplement protocol on day one:
1. Remove the root cause (antimicrobial, antifungal, or reduce toxin/environmental source)
2. Restore depleted cofactors (B-vitamins, CoQ10, carnitine — based on which markers are elevated)
3. Support Phase II detox (glutathione, NAC, glycine)
4. Recolonize the gut (diverse probiotics, *S. boulardii*)
5. Repair gut barrier (L-glutamine, zinc carnosine, collagen peptides)
6. Retest in 3-6 months to confirm resolution

### Step 6: Set a Retest Window

OAT markers are dynamic — they respond to treatment. Set a retest window at the initial visit so the patient has a checkpoint:
- Antifungal protocols: Retest at 8-12 weeks
- Mitochondrial support: Retest at 12 weeks
- Detox or toxin-related protocols: Retest at 3-6 months depending on clearance timeline

---

## 11. Great Plains vs. MosaicDX: Which OAT Panel to Order

The two primary OAT labs functional medicine practitioners use are Great Plains Laboratory (now part of Mosaic Diagnostics) and MosaicDX. The original Great Plains OAT established the clinical standard for FM practice; MosaicDX continues that lineage.

| Dimension | Great Plains / MosaicDX OAT | Other OAT Offerings (Genova, etc.) |
|-----------|---------------------------|----------------------------------|
| **Microbial markers** | Comprehensive — HPHPA, 4-cresol, arabinose, tartaric acid, full Clostridia panel | Variable; many lack HPHPA |
| **Neurotransmitter metabolites** | Yes (HVA, VMA, 5-HIAA, kynurenic/xanthurenic) | Varies by panel |
| **Oxalate section** | Yes (oxalic acid, glyceric acid, glycolic acid) | Typically yes |
| **Detox markers** | Yes (glucaric acid, pyroglutamic acid, alpha-OHbutyrate) | Varies |
| **Nutritional markers** | Extensive B-vitamin functional markers | Varies |
| **8-OHdG** | Yes | Varies |
| **Sample type** | First morning urine | First morning urine |

Rule of thumb: MosaicDX OAT is the reference standard for FM practice because of its comprehensive microbial marker panel — particularly the HPHPA and 4-cresol Clostridia markers that many other panels lack entirely. If you cannot run HPHPA, you cannot identify Clostridia-driven neurotransmitter disruption. That is a significant clinical blind spot in complex patients.

---

## 12. How to Explain OAT Results to Patients

OAT reports are visually overwhelming for most patients. Dozens of unfamiliar markers, color-coded out-of-range flags, and technical nomenclature across multiple sections. The goal of the follow-up visit is not to walk through every marker — it is to give the patient a clear narrative about what is happening in their body and what they are going to do about it.

### The "Three Windows" Framework

Frame the OAT as three windows into their physiology:

**1. "The energy window"** — *"This section shows how your cells are making energy. Here's what we found and why it explains your fatigue and exercise intolerance."*
Use: Mitochondrial section markers

**2. "The gut window"** — *"Your gut is producing certain chemicals that we can detect in your urine. This tells us what's overgrowing and how it's affecting your mood, focus, and energy."*
Use: Gut microbial markers — arabinose for Candida, HPHPA for Clostridia

**3. "The stress-and-detox window"** — *"Your liver's detox system is under pressure. This tells us whether it's keeping up with the load — and where it needs support."*
Use: Detox markers

### Patient Communication Principles

- **Lead with the symptom connection.** "This explains why you've been so exhausted after exercise" lands better than "your succinic acid is 2.3 times the upper reference."
- **Identify 2-3 findings, not every elevated marker.** One coherent root cause narrative is more actionable than a list of abnormalities. Patients who receive too much information act on none of it.
- **Use plain language for organisms.** "There's a yeast called Candida that's been overgrowing in your gut" is a concept patients can hold. "Arabinose is 3x the upper limit of normal" is not.
- **Give three action items maximum.** Prioritize the root cause. Not every supplement that could theoretically help.
- **Show the retesting plan.** Patients tolerate complex protocols better when they understand there is a clear checkpoint. "We will retest in 12 weeks and see how these markers have responded to treatment."

---

13. Case Studies

Case Study 1: Post-Antibiotic Dysbiosis — Fatigue, Brain Fog, and Recurrent Yeast Infections

Patient: 38-year-old female. Chief complaint: 2-year history of fatigue, diffuse brain fog, sugar cravings, post-meal bloating, and recurrent vaginal yeast infections. History of five antibiotic courses over the previous three years for recurrent UTIs and a sinus infection.

OAT Findings:

• Arabinose: 3x upper limit of normal (active Candida overgrowth)
• Tartaric acid: Elevated (Candida; also inhibits Krebs cycle malate dehydrogenase)
• Oxalic acid: Elevated (fungal-driven oxalate production — the triple pattern)
• HPHPA: Elevated (Clostridia overgrowth — post-antibiotic)
• 4-Cresol: Borderline elevated
• HVA:VMA ratio: Elevated (DBH inhibition confirmed — dopamine/norepinephrine imbalance)
• Glucaric acid: Elevated (hepatic Phase I under strain from fungal metabolite load)
• Alpha-hydroxybutyric acid: Elevated (early glutathione depletion)
• Lactic acid: Mildly elevated (secondary Krebs disruption from tartaric acid inhibition)

Clinical Interpretation:

This is the classic post-antibiotic dysbiosis OAT signature. Active Candida overgrowth is driving oxalate accumulation and secondary Krebs cycle impairment via tartaric acid. Concurrent Clostridia overgrowth — likely enabled by antibiotic disruption of competing flora — is inhibiting dopamine-beta-hydroxylase, explaining the anxiety and mood dysregulation component that this patient mentioned as an afterthought. The hepatic detox system is compensating but glutathione reserves are thinning. Two gut organisms. One OAT report. A coherent clinical story.

Protocol:

1. 4-week antifungal phase: Low-sugar, low-yeast diet; berberine 500mg three times daily; oregano oil extract; Saccharomyces boulardii 10B CFU daily
2. Oxalate support: Calcium citrate 500mg with main meals; P-5-P 50mg/day
3. Clostridia support: S. boulardii continued; reintroduction of diverse Lactobacillus/Bifidobacterium after antifungal phase
4. Glutathione support: NAC 600mg twice daily; liposomal glutathione 500mg/day
5. Retest OAT at 12 weeks

Outcome: At 12-week retest, arabinose normalized. HPHPA reduced by approximately 80%. Oxalic acid decreased by 60%. Patient reported a 70% improvement in brain fog and anxiety by week 8, with energy stabilizing around the same timeframe. She described the mood shift as "not feeling like myself for two years and then recognizing myself again."

(De-identified; clinical pattern informed by Peter Kozlowski, MD practice and OAT clinical literature)

---

Case Study 2: Statin-Induced Mitochondrial Suppression with Functional Nutrient Depletion

Patient: 52-year-old male. Chief complaint: Progressive fatigue, exercise intolerance, and difficulty concentrating over 18 months. History: statin therapy initiated 20 months prior for elevated LDL. Lipid panel and CMP unremarkable. Cardiologist attributed symptoms to deconditioning.

OAT Findings:

• Pyruvic acid: Elevated (glycolysis-to-Krebs entry impaired)
• Lactic acid: Elevated (anaerobic metabolism predominating)
• Succinic acid: Elevated (Complex II dysfunction)
• Adipic acid: Elevated (fatty acid beta-oxidation block)
• Beta-OH-beta-methylglutaric acid: Elevated (CoQ10 deficiency indicator — HMG-CoA reductase suppressed)
• Glutaric acid: Elevated (functional riboflavin/B2 deficiency)
• Methylmalonic acid: Mildly elevated (functional B12 deficiency)
• Serum B12 at prior visit: 380 pg/mL ("within reference range")

Clinical Interpretation:

Statin-related mitochondrial suppression. HMG-CoA reductase inhibition — the therapeutic mechanism of statins — also suppresses the CoQ10 biosynthesis pathway, which shares the same upstream mevalonate pathway. CoQ10 is essential for electron transport chain function. The elevated beta-OH-beta-methylglutaric acid is the OAT's indicator of this depletion. Combined with functional riboflavin deficiency (glutaric acid elevated), the Krebs cycle is impaired at multiple levels. The serum B12 of 380 pg/mL appeared adequate — elevated MMA on OAT revealed the cellular reality.

This patient had been told his fatigue was deconditioning. The OAT provided the mechanism that conventional labs missed.

Protocol:

1. Statin discussion: Reviewed risk:benefit with patient and referring cardiologist. Patient elected to temporarily discontinue pending retesting.
2. CoQ10 (ubiquinol): 400mg/day with a fat-containing meal
3. Riboflavin (B2): 100mg/day
4. Methylcobalamin (B12): 1mg/day sublingual
5. L-carnitine: 2g/day (fatty acid oxidation support)
6. Magnesium malate: 400mg/day (Krebs cycle cofactor support)
7. Retest OAT at 12 weeks

Outcome: Meaningful improvement in energy and exercise tolerance by week 6. Patient described being able to complete workouts again for the first time in over a year. Repeat OAT at 12 weeks showed normalization of lactic acid, succinic acid, and adipic acid; CoQ10 marker substantially improved; MMA normalized.

(De-identified; statin-mitochondria pattern based on clinical literature and practice patterns)

---

14. FAQ

Q: What is the organic acids test used for in functional medicine?

A: The organic acids test (OAT) is a comprehensive urine test used in functional medicine to assess mitochondrial energy production, gut microbial activity (yeast overgrowth, Clostridia, bacterial dysbiosis), oxalate accumulation, hepatic detoxification capacity, neurotransmitter metabolite profiles, and functional vitamin and cofactor status. A single first-morning urine sample provides a functional metabolic snapshot that conventional serum labs typically miss. It is particularly valuable for patients with chronic fatigue, brain fog, mood disorders, gut dysfunction, or unexplained symptoms despite "normal" bloodwork.

---

Q: How is the OAT different from standard blood tests?

A: Standard blood tests measure circulating levels of substances — hormones, nutrients, metabolites — at a single point in time. The OAT measures metabolic byproducts in urine: the downstream products of biochemical pathways over a longer collection window. This makes the OAT a functional test. It shows whether energy pathways, detox systems, and microbial populations are working correctly, rather than just whether a nutrient level is within a reference range. Serum B12 may be "normal" while elevated methylmalonic acid on OAT reveals that cellular B12 utilization is impaired — a distinction that changes the clinical picture entirely.

---

Q: What does it mean when arabinose is high on the OAT?

A: Elevated arabinose on the OAT is the most reliable urinary marker for Candida (yeast) overgrowth. Candida ferments glucose and produces arabinitol, which converts to arabinose and is excreted in urine. When arabinose is elevated alongside tartaric acid — another Candida fermentation byproduct — Candida overgrowth is strongly implicated. Associated symptoms include sugar cravings, bloating, brain fog, fatigue, and recurrent yeast infections. Treatment focuses on antifungal diet, herbal antifungals such as berberine and oregano oil, and probiotic recolonization with Saccharomyces boulardii and Lactobacillus species.

---

Q: What are HPHPA and 4-cresol on the OAT, and why do they matter?

A: HPHPA (3-(3-hydroxyphenyl)-3-hydroxypropionic acid) and 4-cresol are metabolites produced by Clostridia bacteria in the gut that directly inhibit dopamine-beta-hydroxylase (DBH) — the enzyme responsible for converting dopamine to norepinephrine. When these markers are elevated, dopamine accumulates while norepinephrine is depleted, producing a neurochemical imbalance that manifests as anxiety, OCD-like behaviors, mood dysregulation, and poor concentration. HPHPA and 4-cresol have been studied extensively in autism spectrum disorder research, but they are clinically significant in adults with mood and behavioral symptoms as well. When HPHPA is elevated, the HVA:VMA ratio in the neurotransmitter section provides biochemical confirmation of DBH inhibition.

---

Q: What causes high oxalates on an organic acids test?

A: High oxalates on OAT have three distinct sources. First, dietary — high intake of oxalate-rich foods such as spinach, almonds, beets, and chocolate. Second, endogenous — the glyoxylate metabolic pathway produces oxalate when vitamin B6 (pyridoxal-5-phosphate) is deficient or when large amounts of vitamin C are consumed. Third, fungal — Candida produces oxalic acid directly as a metabolic byproduct, which is why arabinose, tartaric acid, and oxalic acid frequently elevate together. Identifying the source is essential because the treatment differs: dietary sources require dietary modification, endogenous sources require B6 supplementation, and fungal sources require antifungal treatment first.

---

Q: How do I treat elevated mitochondrial markers on OAT?

A: Treatment for elevated OAT mitochondrial markers is targeted to which markers are elevated and which cofactors are implicated. Common interventions include: thiamine (B1) 100-300mg/day for elevated pyruvate and lactate; riboflavin (B2) 100mg/day for elevated glutaric acid, adipic acid, or Complex II markers; CoQ10 (ubiquinol form) 200-400mg/day for Krebs cycle impairment — especially critical if the patient is on statins; L-carnitine 2g/day for elevated fatty acid oxidation markers; and magnesium malate for general Krebs cycle cofactor support. Always address root causes — statin use, mold exposure, mitochondrial toxins — before simply stacking supplements on top of a continuing insult.

---

Q: Can the OAT detect mold or mycotoxin exposure?

A: The OAT does not directly measure mycotoxins. However, several OAT markers are indirect indicators of mycotoxin-related metabolic disruption: elevated fumaric acid (fumarase inhibition associated with mycotoxins), elevated glucaric acid (liver detox upregulation consistent with toxin load), and a characteristic pattern of multiple Krebs cycle intermediates elevated simultaneously. For direct mycotoxin identification, a urine mycotoxin panel — RealTime Labs or Great Plains MycoTOX — is required. OAT findings can guide clinical suspicion and prioritize that testing.

---

Q: How often should I retest the OAT after starting treatment?

A: For most FM protocols: retest at 8-12 weeks for antifungal and antimicrobial treatments, and at 12 weeks for mitochondrial support protocols. Detoxification and toxin-related protocols may require a longer retest window — 3-6 months — depending on the extent of source clearance. If symptoms have improved and you want biochemical confirmation before tapering the protocol, 8 weeks is generally sufficient to see meaningful marker changes from an effective antifungal or antimicrobial intervention.

---

Citations

1. Shaw W et al. "Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features." Clin Chem. 1995 Aug;41(8 Pt 1):1094-104. PMID: 7628083 (Foundational OAT paper — arabinose and Krebs cycle metabolites as markers)

2. Eisen DP et al. "Urine D-arabinitol/L-arabinitol ratio in diagnosing Candida infection in patients with haematological malignancy and HIV infection." Diagn Microbiol Infect Dis. 2002 Jan;42(1):37-42. PMID: 11821170 (Arabinitol as Candida biomarker in urine)

3. Shaw W. "Inhibition of the Beta-oxidation Pathway of Fatty Acids and Dopamine-Beta-hydroxylase by Phenyl Derivatives of Short-Chain Fatty Acids from Gastrointestinal Clostridia Bacteria is a (the) Major Cause of Autism." Integr Med (Encinitas). 2023 May;22(2):18-25. PMID: 37363147 / PMCID: PMC10289112 (HPHPA and 4-cresol DBH inhibition mechanism)

4. Lord RS, Bralley JA. "Clinical applications of urinary organic acids. Part 2. Dysbiosis markers." Altern Med Rev. 2008 Dec;13(4):292-306. PMID: 19152477

5. Lord RS, Bralley JA. "Clinical applications of urinary organic acids. Part I: Detoxification markers." Altern Med Rev. 2008 Sep;13(3):205-15. PMID: 18950247

6. Daniel SL et al. "Forty Years of Oxalobacter formigenes, a Gutsy Oxalate-Degrading Specialist." Appl Environ Microbiol. 2021 Aug 26;87(18):e0054421. PMID: 34190610 / PMCID: PMC8388816 (Gut microbiome role in oxalate metabolism)

7. Noonan SC, Savage GP. "Oxalate content of foods and its effect on humans." Asia Pac J Clin Nutr. 1999 Mar;8(1):64-74. PMID: 24393738

---

Ready to Cut OAT Documentation Time in Half?

OAT reports are dense. Interpreting every marker category, building root cause narratives, and documenting a prioritized protocol takes 20-40 minutes per patient — minimum. In a high-volume functional medicine practice, that adds up fast.

HANS reads OAT results with you. AI-assisted interpretation built specifically for functional medicine — pattern recognition across all six marker categories, root cause narrative generation, protocol suggestions, and documentation-ready summaries that integrate directly into your clinical workflow.

Practitioners using HANS report cutting OAT documentation time significantly, without losing the clinical nuance that makes FM worth doing. The patterns are there. HANS helps you see them faster and document them cleanly.

See how HANS handles OAT interpretation → Start with HANS

---